Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis. 2006

Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
Department of Biological Science, SungKyunKwan University, 300 Chunchun-Dong, Jangan-Gu, Suwon City, Kyunggi 440-746, Korea.

Isonicotinic acid hydrazide (Isoniazid, INH) is one of the major drugs worldwide used in the chemotherapy of tuberculosis. Many investigators have emphasized that INH activation is associated with mycobacterial catalase-peroxidase (katG). However, INH activation mechanism is not completely understood. In this study, katG of M. bovis BCG was separated and purified into two katGs, katG I (named as relatively higher molecular weight than katG II) and katG II, indicating that there is some difference in protein structure between two katGs. The molecular weight of the enzymes of katG I and katG II was estimated to be approximately 150,000 Da by gel filtration, and its subunit was 75,000 Da as determined by SDS-PAGE, indicating that purified enzyme was composed of two identical subunits. The specific activity of the purified enzyme katG I was 991.1 (units/mg). The enzymes were then investigated in INH activation by using gas chromatography mass spectrometry (GC-MS). The analysis of GC-MS showed that the katG I from M. bovis BCG directly converted INH (Mr, 137) to isonicotinamide (Mr, 122), not to isonicotinic acid (Mr, 123), in the presence or absence of H2O2. Therefore, this is the first report that katG I, one of two katGs with almost same molecular weight existed in M. bovis BCG, converts INH to isonicotinamide and this study may give us important new light on the activation mechanism of INH by KatG between M. bovis BCG and M. tuberculosis.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007539 Isonicotinic Acids Heterocyclic acids that are derivatives of 4-pyridinecarboxylic acid (isonicotinic acid). Isonicotinic Acid,Acid, Isonicotinic,Acids, Isonicotinic
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010544 Peroxidases Ovoperoxidase
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
August 2000, Biochemistry,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
August 1992, Nature,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
October 2002, Molecular microbiology,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
September 1998, Journal of clinical microbiology,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
March 2007, Biochemistry,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
June 1967, Journal of general microbiology,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
June 1967, Journal of general microbiology,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
February 1959, Gruzlica (Warsaw, Poland : 1926),
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
January 1957, Deltion Hellenikes Mikrobiologikes kai Hygieinologikes Hetaireias,
Sung-Koo Kang, and Jong-Ho Lee, and Young-Choon Lee, and Cheorl-Ho Kim
December 1952, Annales de l'Institut Pasteur,
Copied contents to your clipboard!